Is It Time to Change the Independent Dispute Resolution Process of the No Surprises Act? Read More February 1, 2026
Premise-Crossover Merger: Inside the $2B Push for a New Employer Health Model Read More February 1, 2026
Clinical Trial Holds Cast Doubt on Approval Chances of Regenxbio Gene Therapy for Rare Disease Read More February 1, 2026